• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    GRAIL, Inc. - Common Stock (NQ: GRAL )

    14.80 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about GRAIL, Inc. - Common Stock

    Strategic Buy Lights Up This Biotech Stock: Time to Invest?
    Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. 
    Via MarketBeat
    3 Spinoff Stocks You Should Buy Now: July 2024
    Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early. 
    Via InvestorPlace
    3 Biotech Stocks Turning DNA Dreams Into Dollars
    Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks. 
    Via InvestorPlace
    Dear AMZN Stock Fans, Mark Your Calendars for July 16
    Amazon stock is worth watching for AMZN investors on July 16 as that's when the e-commerce company will start its Prime Day sales. 
    Via InvestorPlace
    Tesla Cybertruck Recalls: What to Know as Tesla Recalls Thousands of EVs
    The Tesla Cybertruck recalls continue with the electric vehicle (EV) company seeking to repair issues with thousands of the trucks. 
    Via InvestorPlace
    Topics Electric Vehicles Product Recall
    Exposures Electric Vehicles Legal Product Safety
    Earnings Scheduled For November 12, 2024
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
    Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of GRAIL, confirming Illumina's stance. The ruling nullifies a €432 million... 
    Via Benzinga
    GRAL Stock Earnings: GRAIL Reported Results for Q2 2024
    GRAIL just reported results for the second quarter of 2024. 
    Via InvestorPlace
    3 Top Cancer Treatment Stocks to Buy Now
    These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term. 
    Via InvestorPlace
    Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
    Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why Is SolarEdge (SEDG) Stock Down 17% Today?
    SolarEdge stock is falling on Tuesday as SEDG investors react to one of the company's customers goin bankruptcy without paying back debts. 
    Via InvestorPlace
    Topics Bankruptcy
    Exposures Financial Legal
    GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today
    New biotech stock Grail begins trading on the Nasdaq today. Here's what investors need to know about GRAL stock. 
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.